Insulin-IGF-1 signaling: The longevity pathway every centenarian shares
The insulin/IGF-1 signaling pathway is the most replicated longevity mechanism in biology. Learn how it works, what centenarians teach us, and how to optimize it for a longer life.
If there’s one biological pathway that every longevity researcher agrees on, it’s this one. The insulin/IGF-1 signaling (IIS) pathway has been shown to regulate lifespan in every organism ever tested — from yeast and worms to flies, mice, dogs, and humans. Reduce its activity, and organisms live dramatically longer. In the nematode C. elegans, disrupting IIS can extend lifespan by up to tenfold.
The evidence in humans is equally compelling, though more nuanced. Ashkenazi Jewish centenarians carry an overrepresentation of mutations that weaken IGF-1 receptor activity. Italian centenarians show preserved insulin sensitivity alongside lower IGF-1 levels. Across populations, the pattern repeats: people who live the longest tend to have efficient insulin signaling with moderate — not high — growth factor activity.
This is not a theoretical concern. The IIS pathway is active in your body right now, and every meal you eat, every workout you do, and every night of sleep you get modulates it. Understanding this pathway is understanding the central mechanism of aging itself.
What you’ll learn:
- Why the IIS pathway is the most replicated longevity mechanism in biology
- What centenarian studies reveal about optimal insulin and IGF-1 signaling
- How to optimize this pathway through diet, exercise, fasting, and lifestyle
What is the insulin/IGF-1 signaling pathway?
The IIS pathway is an evolutionarily conserved signaling cascade that detects nutrient availability and regulates growth, metabolism, reproduction, and lifespan accordingly. It operates through two parallel but interconnected arms:
Quick definition: The insulin/IGF-1 signaling (IIS) pathway is an ancient nutrient-sensing network that balances growth and repair — high IIS promotes cell growth and reproduction at the cost of accelerated aging, while reduced IIS activates protective and repair mechanisms that extend lifespan.
The two arms of IIS
Insulin arm (metabolic):
- Responds to blood glucose and nutrient intake
- Promotes glucose uptake, fat storage, and protein synthesis
- Chronic hyperactivation (insulin resistance) drives metabolic disease
- Measured by: fasting insulin, HOMA-IR, HbA1c, fasting glucose
IGF-1 arm (growth):
- Responds to growth hormone and dietary protein (especially animal protein)
- Promotes cell proliferation, tissue growth, and inhibits apoptosis
- Chronic elevation drives cancer risk and suppresses autophagy
- Measured by: serum IGF-1
Both arms converge on shared downstream targets — most critically, the mTOR pathway and the FOXO transcription factors.
The science behind IIS and longevity
The most replicated finding in aging biology
The connection between reduced IIS and extended lifespan has been demonstrated across virtually every model organism:
| Organism | IIS mutation/intervention | Lifespan extension |
|---|---|---|
| S. cerevisiae (yeast) | Ras/PKA pathway reduction | 2–3x |
| C. elegans (worm) | daf-2 (insulin receptor) mutation | Up to 10x |
| D. melanogaster (fly) | InR/chico mutations | 50–85% |
| M. musculus (mouse) | GH/IGF-1 receptor mutations | 30–60% |
| C. familiaris (dog) | Small breeds (lower IGF-1) | 2–3 years longer |
| H. sapiens (human) | Centenarian IGF-1R mutations | Associated with extreme longevity |
The mechanism is consistent across species: when the IIS pathway is less active, organisms shift from “growth mode” to “maintenance and repair mode.” This triggers:
- Increased autophagy — Cells activate self-cleaning processes that remove damaged proteins and organelles
- Reduced mTOR activity — Less cell proliferation, less cancer risk, more cellular quality control
- FOXO activation — These transcription factors upregulate antioxidant defenses, DNA repair, immune function, and stress resistance
- AMPK activation — The metabolic switch that promotes fat burning and mitochondrial biogenesis
- Reduced inflammation — Lower NF-κB activation and reduced pro-inflammatory cytokine production
What centenarians teach us
The human evidence, while more complex than animal models, consistently points in the same direction.
The Ashkenazi Jewish centenarian study: Researchers found an overrepresentation of heterozygous mutations in the IGF-1 receptor gene among Ashkenazi Jewish centenarians. These individuals had higher serum IGF-1 levels but weaker IGF-1 receptor activity — meaning the signal was present but partially muted. This suggests that partial IIS attenuation, not complete suppression, is the human longevity pattern.
The Italian centenarian study: Centenarians from southern Italy showed remarkably preserved glucose tolerance and insulin sensitivity alongside lower plasma IGF-1 compared to aged (non-centenarian) controls. A study of 466 healthy subjects found that insulin resistance actually decreased in those aged 90–100, suggesting efficient insulin action is selected for in extreme longevity.
The female height connection: In women, lower IIS scores (measured by insulin, glucose, and IGF-1 composite) are significantly associated with lower body height and improved old-age survival. This aligns with the animal data: smaller organisms with lower growth signaling tend to live longer.
The practical pattern: Centenarians don’t have zero IIS. They have efficient insulin signaling (good sensitivity, not resistance) combined with moderate growth factor activity (IGF-1 in the lower-normal range). They’re not growth-suppressed — they’re growth-optimized.
New to these pathways? Our guides on mTOR and AMPK explain the downstream mechanisms in detail.
The growth-longevity tradeoff
This pathway illustrates biology’s fundamental tradeoff:
| High IIS (growth mode) | Low IIS (maintenance mode) |
|---|---|
| Rapid growth and reproduction | Slower growth, delayed reproduction |
| High protein synthesis | Increased autophagy and cellular repair |
| mTOR activation | AMPK and FOXO activation |
| Suppressed immune surveillance | Enhanced stress resistance |
| Accelerated aging | Extended lifespan |
Evolution optimized IIS for reproduction, not longevity. In environments of abundance, the pathway drives growth and reproduction at the expense of long-term maintenance. In scarcity, it shifts toward survival and repair. Modern life — with constant food availability, high protein intake, and minimal fasting — keeps IIS chronically elevated, which may be one of the fundamental reasons why chronic disease rates have climbed alongside food abundance.
7 strategies to optimize the IIS pathway for longevity
The goal isn’t to suppress IIS entirely — it’s to create the cycling between growth and repair that centenarians naturally maintain.
1. Improve insulin sensitivity
Why it works: Insulin sensitivity is the efficiency of insulin signaling. High sensitivity means less insulin is needed to manage blood glucose — which means less IIS pathway activation for the same metabolic work. Insulin resistance, by contrast, requires more insulin to achieve the same effect, chronically hyperactivating the pathway.
How to do it:
- Regular exercise is the single most powerful insulin sensitizer — both aerobic and resistance training
- Maintain healthy body composition — visceral fat is the primary driver of insulin resistance
- Prioritize low-glycemic carbohydrates: vegetables, legumes, whole grains, berries
- Read our complete guide on how to improve insulin sensitivity
Expected results: Measurable improvements in fasting insulin and HOMA-IR within 4–8 weeks. Long-term insulin sensitivity is one of the strongest predictors of healthy aging.
2. Practice strategic fasting
Why it works: Fasting is the most direct way to shift the IIS pathway from growth to repair mode. During fasting, insulin drops, IGF-1 decreases, AMPK activates, mTOR is suppressed, and autophagy engages. This is the “maintenance mode” that centenarians’ genetics partially mimic constitutively.
How to do it:
- Time-restricted eating (16:8 or 18:6) provides daily IIS modulation
- Periodic 24-hour fasts (1–2x per month) deepen the repair window
- Extended fasting (48–72 hours, quarterly, under medical supervision) produces the most profound pathway shifts
- Compare approaches: intermittent fasting vs caloric restriction
Expected results: Immediate IIS reduction during each fast. Chronic fasting practice may improve baseline insulin sensitivity and lower IGF-1 over time.
3. Moderate protein intake intelligently
Why it works: Dietary protein — especially animal protein rich in leucine and methionine — is the strongest dietary activator of IGF-1 and mTOR. Moderating protein in midlife reduces chronic IIS activation while maintaining enough for tissue repair.
How to do it:
- Ages 18–50: Standard protein needs (0.7–1.0 g per pound / 1.5–2.2 g/kg)
- Ages 50–65: Consider moderating to 0.5–0.7 g per pound (1.1–1.5 g/kg), shifting toward plant sources
- Ages 65+: Increase protein to prevent sarcopenia and frailty (0.7–1.0 g per pound)
- Prioritize plant protein where possible — it stimulates IGF-1 less than animal protein
- How much protein after 40 provides detailed age-specific guidance
Expected results: 10–30% IGF-1 reduction when shifting from high animal protein to moderate/plant-based protein.
4. Exercise to activate AMPK
Why it works: Exercise activates AMPK — the IIS pathway’s counterbalance. AMPK inhibits mTOR, promotes autophagy, enhances mitochondrial biogenesis, and improves insulin sensitivity. Regular exercise creates the cycling between growth (post-exercise mTOR activation for muscle repair) and repair (AMPK-dominant recovery periods) that mirrors the centenarian pattern.
How to do it:
- Combine resistance training (mTOR activation for muscle) with aerobic exercise (AMPK activation for metabolic health)
- HIIT is particularly potent for AMPK activation
- Train in a fasted or low-carbohydrate state occasionally to amplify AMPK activation
- Ensure adequate recovery — the AMPK-dominant recovery phase is where many longevity benefits occur
Expected results: Improved insulin sensitivity, enhanced autophagy capacity, and better mTOR/AMPK cycling within 4–8 weeks.
5. Reduce chronic inflammation
Why it works: Chronic inflammation (inflammaging) impairs insulin sensitivity and dysregulates the IIS pathway. Rising hs-CRP and IL-6 create insulin resistance, which forces higher insulin secretion, which hyperactivates IIS — a vicious cycle that accelerates aging.
How to do it:
- Anti-inflammatory diet: fatty fish, olive oil, berries, leafy greens, nuts
- Adequate omega-3 fatty acids (EPA+DHA 2–3 g daily)
- Regular exercise (the most potent anti-inflammatory lifestyle intervention)
- Adequate sleep — sleep deprivation increases inflammatory markers within 1–2 nights
- Stress management — chronic cortisol promotes inflammatory signaling
Expected results: Reduced inflammatory markers and improved insulin sensitivity within 4–8 weeks of anti-inflammatory lifestyle changes.
6. Protect deep sleep
Why it works: Sleep deprivation impairs insulin sensitivity within a single night and dysregulates growth hormone secretion patterns. Deep sleep is when healthy GH pulsatility occurs — the cycling pattern that creates beneficial IGF-1 surges followed by clearance, rather than chronic elevation.
How to do it:
- Target 7–8 hours with emphasis on deep sleep quality
- Maintain consistent sleep timing — IIS pathway regulation is circadian-dependent
- Avoid eating within 3 hours of bedtime — late-night insulin spikes disrupt overnight IIS cycling
- Address sleep disorders — sleep apnea dramatically impairs insulin sensitivity
Expected results: Restored insulin sensitivity and normalized GH/IGF-1 cycling within 1–2 weeks of improved sleep.
7. Monitor your IIS biomarkers
Why it works: The IIS pathway is measurable through standard blood tests. Knowing your levels allows data-driven optimization rather than guesswork.
What to test:
- Fasting insulin — The most direct measure of insulin arm activity. Target <8 μIU/mL, optimal <5 μIU/mL
- Fasting glucose — Should be 70–100 mg/dL
- HOMA-IR — Calculated from fasting insulin and glucose. Target <1.5
- HbA1c — Reflects 3-month average glucose. Target <5.5%
- IGF-1 — Growth arm activity. Target 100–160 ng/mL for adults over 40
- hs-CRP — Inflammatory status affecting IIS. Target <1.0 mg/L
Expected results: Baseline understanding of your IIS status. Repeat every 6–12 months to track trajectory.
The information provided does not replace professional medical advice. Consult your healthcare provider for personalized biomarker interpretation.
How to track IIS-related health daily
Key metrics to monitor
| Metric | Optimal range | What it indicates |
|---|---|---|
| Body fat % | Healthy range by age/sex | Insulin sensitivity proxy; excess visceral fat drives insulin resistance |
| HRV | Age-adjusted; higher is better | Metabolic and autonomic health; low HRV correlates with insulin resistance |
| Exercise consistency | 4+ sessions/week | AMPK activation frequency; key for IIS pathway cycling |
| Post-meal energy | Stable (no crashes) | Glucose regulation; energy crashes suggest insulin dysregulation |
| Waist circumference | <37 in / 94 cm (men), <32 in / 80 cm (women) | Visceral fat; strongest lifestyle predictor of insulin resistance |
How SuperAge helps you optimize the longevity pathway
The IIS pathway is regulated by everything you do daily — and SuperAge tracks the metrics that matter most.
Metabolic health monitoring
SuperAge tracks body composition, weight trends, and exercise patterns — the metrics most directly tied to insulin sensitivity and IIS pathway status.
Activity and recovery balance
Through training load and HRV monitoring, SuperAge reveals whether you’re achieving the mTOR/AMPK cycling that centenarians maintain naturally — periods of growth stimulus followed by adequate repair.
Your biological age, tracked
The IIS pathway is arguably the single most important determinant of biological aging rate. SuperAge calculates your biological age from multiple health metrics, giving you a tangible measure of how effectively your lifestyle is optimizing this ancient longevity pathway.
Frequently asked questions
Is the insulin/IGF-1 pathway the same as insulin resistance?
No — they’re related but distinct. The IIS pathway is the normal signaling cascade activated by insulin and IGF-1. Insulin resistance is a pathological state where cells become less responsive to insulin, requiring higher insulin levels — which chronically hyperactivates the pathway. Paradoxically, insulin resistance means cells respond poorly to insulin’s metabolic signals while the growth-promoting (pro-aging) downstream effects continue. Improving insulin sensitivity (not just lowering glucose) is the key to healthy IIS.
Do centenarians eat differently?
Centenarian populations share some dietary patterns: moderate caloric intake, emphasis on plant-based foods, regular fasting (often culturally or religiously motivated), and moderate protein consumption. The Blue Zones — regions with the highest centenarian concentrations — feature diets heavy in legumes, vegetables, and whole grains with modest animal protein. These dietary patterns naturally moderate IIS activity without deliberate optimization.
Can you test your IIS pathway activity?
Yes — through standard blood biomarkers. Fasting insulin is the most direct measure of the insulin arm; IGF-1 measures the growth arm. HOMA-IR (calculated from fasting insulin and glucose) provides an integrated assessment. HbA1c adds a 3-month glucose perspective. Together, these markers give a comprehensive picture of your IIS pathway status for under $100 at most labs.
Is caloric restriction necessary for longevity?
Not necessarily. What matters is IIS pathway modulation — and caloric restriction is just one way to achieve it. Exercise, fasting, protein moderation, and maintaining insulin sensitivity all modulate IIS without chronic caloric restriction. The centenarian evidence suggests that efficient insulin sensitivity (not caloric restriction per se) is the common denominator. You can achieve similar pathway benefits through strategic lifestyle optimization while eating adequate calories.
How does this pathway connect to cancer?
High IIS promotes cell proliferation and inhibits apoptosis (programmed cell death) — both of which favor cancer development. IGF-1 is a particularly potent cancer promoter because it tells cells to grow and prevents them from self-destructing when damaged. This is why Laron syndrome patients (very low IGF-1) virtually never develop cancer. Moderating IIS activity through lifestyle reduces the pro-proliferative signaling environment that cancer cells exploit.
Key takeaways
- The IIS pathway is the most replicated longevity mechanism: Reducing its activity extends lifespan in every organism tested, from yeast to humans
- Centenarians show efficient insulin + moderate IGF-1: Not suppressed signaling — optimized signaling with preserved sensitivity
- Every lifestyle factor modulates IIS: Diet, exercise, fasting, sleep, stress, and body composition all directly affect this pathway
- The growth-longevity tradeoff is real: High IIS drives growth and reproduction at the cost of accelerated aging and cancer risk
- You can measure it: Fasting insulin, IGF-1, HOMA-IR, and HbA1c together provide a comprehensive IIS assessment
Start optimizing your longevity pathway today
The IIS pathway doesn’t care about supplements, biohacks, or shortcuts. It responds to the fundamentals: how you eat, how you move, how you sleep, and how you manage stress. Centenarians didn’t optimize this pathway consciously — they lived in ways that did it naturally.
You have the advantage of understanding the mechanism. Use it.
Ready to take control? Download SuperAge and start tracking the metrics that reflect your longevity pathway status — body composition, HRV, exercise patterns, and biological age.
References
- Kenyon, C. (2010). The genetics of ageing. Nature, 464(7288), 504–512.
- Vitale, G. et al. (2019). ROLE of IGF-1 System in the Modulation of Longevity: Controversies and New Insights From a Centenarians’ Perspective. Frontiers in Endocrinology, 10, 27.
- Suh, Y. et al. (2008). Functionally significant insulin-like growth factor I receptor mutations in centenarians. PNAS, 105(9), 3438–3442.
- Barbieri, M. et al. (2003). Insulin/IGF-I-signaling pathway: an evolutionarily conserved mechanism of longevity from yeast to humans. American Journal of Physiology, 285(5), E1064–E1071.
- Bartke, A. (2012). Insulin, IGF-1 and longevity. Aging and Disease, 1(2), 147–157.
- Xu, Y. et al. (2018). Late-life targeting of the IGF-1 receptor improves healthspan and lifespan in female mice. Nature Communications, 9, 2394.
- Paolisso, G. et al. (2001). Glucose tolerance and insulin action in healthy centenarians. American Journal of Physiology, 280(3), E466–E471.
- Li, Q. et al. (2021). Insulin signaling regulates longevity through protein phosphorylation in C. elegans. Nature Communications, 12, 4568.
Last updated: 2026-03-13. This article is regularly reviewed to ensure accuracy.
Related Articles
Autophagy: The cellular cleanup system behind healthy aging
Autophagy recycles damaged proteins and organelles. Learn what human research supports, how fasting and exercise may help, and what to track cautiously.
